Canadian Journal of Physiology and Pharmacology
短名 | Can. J. Physiol. Pharmacol. |
Journal Impact | 1.83 |
国际分区 | PHYSIOLOGY(Q4) |
期刊索引 | SCI Q3中科院 4 区 |
ISSN | 0008-4212, 1205-7541 |
h-index | 95 |
国内分区 | 医学(4区)医学药学(4区)医学生理学(4区) |
自 1929 年出版以来,加拿大生理学和药理学杂志是一份月刊,报道生理学、营养学、药理学和毒理学各个方面的当前研究,由公认的专家和科学家贡献。它发表专题讨论会评论和奖励讲座,有时将整个问题或部分问题专门用于其国际读者特别感兴趣的主题。该杂志定期出版“加拿大制造”特别版块,其中包含来自国际知名科学家的特邀评论文章,这些科学家在加拿大接受了一些培训。
期刊主页投稿网址涉及主题 | 生物医学内科学化学内分泌学生物化学遗传学有机化学心理学物理神经科学受体药理学麻醉心脏病学核磁共振放射科细胞生物学酶材料科学病理 |
出版信息 | 出版商: National Research Council of Canada,出版周期: Monthly,期刊类型: journal |
基本数据 | 创刊年份: 1964,原创研究文献占比: 91.13%,自引率:5.90%, Gold OA占比: 7.52% |
平均审稿周期 | 网友分享经验:一般,3-8周 |
平均录用比例 | 网友分享经验:容易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Canadian Society of Pharmacology and Therapeutics
2024-9-17
Nebivolol prevents redox imbalance and attenuates bladder dysfunction induced by cyclophosphamide in mice
2024-9-13
Echocardiographic Assessment of Epicardial Adipose Tissue Thickness as Independent Predictor in Coronary Artery Disease
2024-9-3
Behavioral dynamics of medicinal signaling cells from porcine bone marrow in long-term culture
2024-8-27
Sarcopenia: Recent Advances for Detection, Progression and Metabolic Alterations along with Therapeutic Targets
2024-8-26
Retraction: β-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase
2024-8-23
Retraction: Endothelin axis induces metalloproteinase activation and invasiveness in human lymphatic endothelial cells
2024-8-23
Introduction—Unveiling gender disparity in heart disease
2024-8-1
HFpEF and sex: understanding the role of sex differences
2024-8-1
Cardiovascular and physiological risk factors in women at mid-life and beyond
2024-8-1
Expression of concern: Acrolein induces apoptosis through the death receptor pathway in A549 lung cells: role of p53
2024-7-19
LYSOPHOSPHATIDIC ACID METABOLISM AND SIGNALING IN HEART DISEASE
2024-7-5
Cytochrome P450 1B1 is Critical in the Development of TNF-α, IL-6, and LPS-Induced Cellular Hypertrophy
2024-7-1
Assessing feasibility and sex-related inequity in the Cardiac Rehabilitation Quality Indicators in Manitoba
2024-6-25
The acute effects of dietary nitrate supplementation on postmenopausal endothelial resistance to ischemia reperfusion injury: A randomized, placebo-controlled, double blind, crossover clinical trial
2024-6-20
Correction: Cardiac hypertrophy caused by hyperthyroidism in rats: the role of ATF-6 and TRPC1channels
2024-6-6
Discontinuing semaglutide after weight loss: strategy for weight maintenance and a possible new side effect
2024-6-1
The role of melatonin in preventing amiodarone-induced rat liver damage
2024-6-1
Fishing antioxidant 4-hydroxycoumarin derivatives: synthesis, characterization, and in vitro assessments
2024-6-1
Cardiac Physiology and Pathophysiology in Pregnancy
2024-5-30
Engaging women in decision making about their heart health: A literature review with patients' perspective
2024-5-30
Oral Hormonal Contraceptives and Cardiovascular Risks in Females
2024-5-23
Sex specific considerations in cardiovascular drug therapy
2024-5-23
Chloramphenicol alleviates 5-fluorouracil-induced cellular senescence through activation of autophagy
2024-5-22
Agonists, Inverse Agonists, and Antagonists as Therapeutic Approaches to Manipulate Retinoic Acid-Related Orphan Receptors (RORs)
2024-5-10
Coronary Microvascular Disease in Women: Epidemiology, Mechanisms, Evaluation, and Treatment
2024-5-10
Targeting the vivid facets of apolipoproteins as a cardiovascular risk factor in rheumatoid arthritis
2024-5-1
Salvianolic acid B attenuates diabetic nephropathy through alleviating ADORA2B, NALP3 inflammasome, and NFκB activity
2024-5-1
Formation of a border ischemic zone depends on plasma potassium concentration.
2024-5-1
Azilsartan Prevents Muscle Loss and Fast to Slow-twitch Muscle Fibre Shift in Natural Ageing Sarcopenic Rats
2024-5-1
Unraveling the Molecular Landscape of kAE1: A Narrative Review
2024-4-26
Low-Fat Cheese Ameliorates Glucose Intolerance and Normalizes Insulin Secretion in a Rat Model of Type 2 Diabetes by Promoting β-cell Recovery
2024-4-26
Cardiogenic Shock - Differences Between Males and Females and Sex Specific Risks
2024-4-25
Psychological interventions targeting mental health and stress among females with cardiac disease: a scoping review
2024-4-8
Canadian Society of Pharmacology and Therapeutics
2024-4-1
Sex-specific effects of frailty on cardiac structure and function: insights from preclinical models
2024-3-15
Cardio-rheumatology: the cardiovascular, pharmacological, and surgical risks associated with rheumatological diseases in women
2024-3-15
Epigenetic regulation of sex dimorphism in cardiovascular health
2024-3-1
Effects of prenatal dexamethasone exposure on adult C57BL/6J mouse metabolism and oxidative stress
2024-3-1
Impact of biological sex on valvular heart disease, interventions, and outcomes
2024-3-1
Nitric oxide and potassium channels but not opioid and cannabinoid receptors mediate tramadol-induced peripheral antinociception in rat model of paw pressure withdrawal
2024-3-1
Deciphering MMP9’s dual role in regulating SOD3 through protein–protein interactions
2024-3-1
Vascular effects of midazolam, flumazenil, and a novel imidazobenzodiazepine MP-III-058 on isolated rat aorta
2024-3-1
TLR/mTOR inflammatory signaling pathway: novel insight for the treatment of schizophrenia
2024-3-1
Tribute—Dr. Pawan K. Singal
2024-2-28
Cardioprotective effects of losartan and diminazene against the ischemia/reperfusion injury in hyperthyroidism rats
2024-2-20
Astaxanthin prevents nephrotoxicity through <i>Nrf2/HO-1</i> pathway
2024-2-1
The non-nutritive sweetener sucralose increases β-arrestin signaling at the constitutively active orphan G protein-coupled receptor GPR52
2024-2-1
Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure
2024-2-1
Considerations for choosing an optimal animal model of cardiovascular disease
2024-2-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远